Alzheimer’s researchers seethe over years of missteps after latest drug failure
(By Sharon Begley for STAT) In the wake of disappointing results this week for yet another experimental Alzheimer’s drug, scientists who
Read More
With superbug scourge looming, global group bets on biotechs to turn the tide
(By Damian Garde and Ed Silverman for STAT) Gunning to beat back a global scourge of superbugs, a transatlantic group is
Read MorePoison control centers are getting a surge of calls about ‘natural’ painkiller kratom
(By Eric Boodman for STAT) The herbal supplement seemed like a miracle. Trying to kick an opioid addiction, the middle-aged
Read MoreHealth Care For California’s Undocumented Adults: Uncertainty Remains After U.S. Supreme Court Decision
(By Ana B. Ibarra for California Healthline) Erica Torres is one of the estimated 1.4 million Californians who live without
Read MoreCan a digital health startup prevent diabetes in Medicaid patients?
(By Andrew Joseph for STAT) SAN FRANCISCO — At the headquarters of Omada Health, the exposed ceiling, stocked kitchen, and
Read MoreEmbattled Theranos promises first-ever peek at its science — but doubts abound
(By Meghana Keshavan for STAT) After more than a decade of evasion, Theranos is finally stepping into the scientific spotlight.
Read More30 Percent Of Children’s Readmissions To Hospitals May Be Preventable: Study
(By Michelle Andrews for Kaiser Health News) One of the key indicators of the quality of a hospital’s care is
Read MoreNo Blood Drives in Two Counties in Florida
The Food and Drug Administration requested blood donation centers in two Florida counties, Miami-Dade and Broward, to stop collecting blood
Read MoreAt the DNC, the debate over drug prices gives way to charcuterie and cheese
(By Dylan Scott for STAT) PHILADELPHIA — The drug industry didn’t really feel the heat here at the Democratic National
Read MoreGilead hep C drug prices blamed for England’s health service rationing treatment
(By Ed Silverman for STAT) Faced with budgetary constraints, England’s National Health Service took several controversial steps to delay coverage
Read More